Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.06.2012 | Case report

Gemcitabine

Haemolytic uraemic syndrome in an elderly patient: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Park YJ, Yang K-S, Jung H-S, Nam HC, Jung SH, Kim BG, Kim KY, Kim J-H, Kim Y-O, Yun Y-S.A case of hemolytic uremic syndrome in a lung cancer patient treated with gemcitabine. Tuberculosis and Respiratory Diseases 72: 207-211, No. 2, 29 Feb 2012. Available from: URL: http://dx.doi.org/10.4046/trd.2012.72.2.207 - South Korea Park YJ, Yang K-S, Jung H-S, Nam HC, Jung SH, Kim BG, Kim KY, Kim J-H, Kim Y-O, Yun Y-S.A case of hemolytic uremic syndrome in a lung cancer patient treated with gemcitabine. Tuberculosis and Respiratory Diseases 72: 207-211, No. 2, 29 Feb 2012. Available from: URL: http://​dx.​doi.​org/​10.​4046/​trd.​2012.​72.​2.​207 - South Korea
Metadaten
Titel
Gemcitabine
Haemolytic uraemic syndrome in an elderly patient: case report
Publikationsdatum
01.06.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214060-00072

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Antineoplastics

Case report

Sorafenib

Case report

Antiretrovirals